Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 21, 2008; 14(19): 3085-3087
Published online May 21, 2008. doi: 10.3748/wjg.14.3085
Published online May 21, 2008. doi: 10.3748/wjg.14.3085
Low risk | Limited data | Not recommended | Contraindicated |
Oral mesalamine | Olsalazine | Tetracycline | Methotrexate |
Topical mesalamine | Azathioprine | Sulfonamides | |
Sulfasalazine | 6-Mercaptopurine | ||
Ampicillin | Metronidazole | ||
Cephalosporins | Ciprofloxacin | ||
Corticosteroids | Infliximab | ||
Cyclosporine | Adalimumab | ||
Loperamide |
Low risk | Limited data | Not recommended | Contraindicated |
Oral mesalamine | Olsalazine | Tetracycline | Methotrexate |
Topical mesalamine | Infliximab | Sulfonamides | Cyclosporine |
Sulfasalazine | Adalimumab | Azathioprine | |
Corticosteroids | 6-Mercaptopurine | ||
Loperamide | |||
Metronidazole | |||
Ciprofloxacin |
- Citation: Stengel JZ, Arnold HL. Is infliximab safe to use while breastfeeding? World J Gastroenterol 2008; 14(19): 3085-3087
- URL: https://www.wjgnet.com/1007-9327/full/v14/i19/3085.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3085